Listen to this page using ReadSpeaker
Posts tagged Pixium

Pixium Vision Reports Progress in Development of Two Advanced Bionic Retina Systems

Man wearing Pixium Bionic Retina GlassesWhile several companies and laboratories around the world are at various stages of bionic-retina development, Pixium Vision  located in France, is progressing impressively down two paths for these high-tech, vision-restoring systems. Both approaches show strong, near-term potential for providing meaningful vision to people who are otherwise blind from retinal diseases such as retinitis pigmentosa and age-related macular degeneration (AMD).

Pixium recently announced that its IRIS®II bionic vision system received a CE Mark, the regulatory approval necessary for marketing medical devices and other products in Europe. The IRIS II is further down the company’s clinical development pipeline than its more technologically advanced PRIMA system, which was originally conceptualized by researchers at Stanford University, and is expected to enter a clinical trial later this year for AMD.

Continue Reading…

VISIONS 2015 – Dr. José Sahel Receives Foundation’s Most Prestigious Research Honor

Dr. SahelI’ve known Dr. José Sahel for more than a decade, and every time I’m with him, I’m impressed by his humility and graciousness. He’s not much for rhetoric or small talk, but is always polite and insightful. Dr. Sahel is also very soft-spoken, but I think that’s his secret weapon. He forces you to really listen to what he’s saying.
Continue Reading…

Nouvelle Lumière: French Bionic Retina in a Human Study

A rendering of Pixium's IRIS device.There’s no doubt that 2013 was a milestone year for bionic retinas. Previously approved for sale in Europe, Second Sight’s Argus II Retinal Prosthesis System received marketing approval in February from the U.S. Food and Drug Administration. Also, in July, Retina Implant AG gained European marketing approval for its Alpha IMS retinal implant.
Continue Reading…